Sort
51,593 grants matching “hepatitis”
Altering Hepatitis B Virus assembly through pharmacological intervention
$393,060James C. Gumbart · Georgia Institute Of Technology · R01 · FY2022 · AI
Altering Hepatitis B Virus assembly through pharmacological intervention
$393,060James C. Gumbart · Georgia Institute Of Technology · R01 · FY2024 · AI
Coordination of hepatic fatty acid metabolism
$393,000Michael J. Wolfgang · Johns Hopkins University · R01 · FY2024 · DK
Methods for Safety Evaluation of Vaccination Schedules
$392,999Martin Kulldorff · Harvard Pilgrim Health Care, Inc. · R01 · FY2014 · AI
ALCOHOL/CELLULAR IMMUNITY IN HCV AND HIV INFECTION
$392,992University Of Pennsylvania · R01 · FY2003 · AA
Immune suppressor mechanism in a murine model of hepatitis and liver cancer
$392,983Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Multi-State, Mixed-Methods Evaluation of the Uptake of new Direct Acting Antiviral Regimens for the Treatment of Hepatitus C Virus
$392,963Karen M Clements · Univ Of Massachusetts Med Sch Worcester · R01 · FY2019 · HS
Liver Cirrhosis Network: Longitudinal and Clinical Trial Studies
$392,962Mandana Khalili · University Of California, San Francisco · U01 · FY2021 · DK
A chicken model to study hepatitis E virus pathogenesis
$392,962Xiang-Jin Meng · Virginia Polytechnic Inst And St Univ · R01 · FY2019 · AI
Nutritional Regulation of Cysteine Dioxygenase
$392,952Martha H Stipanuk · Cornell University · R01 · FY2012 · DK
A chicken model to study hepatitis E virus pathogenesis
$392,874Xiang-Jin Meng · Virginia Polytechnic Inst And St Univ · R01 · FY2017 · AI
4/4: The INTEGRATE Study: Evaluating INTEGRATEd care to Improve Biopsychosocial Outcomes of Early Liver Transplant for Alcohol-Associated Liver Disease
$392,871Jessica Leigh Mellinger · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2024 · AA
Novel Roles of Cullin-RING E3 Ligases in Liver Pathophysiology
$392,869Tiangang Li · University Of Oklahoma Hlth Sciences Ctr · R01 · FY2023 · DK
DECISION TO TREAT--DENTAL PRACTICE AS RISK BEHAVIOR
$392,864Columbia University Health Sciences · R01 · FY2000 · DE
Sphingosine-1-phosphate Signaling and the Chronic Glucocorticoid Exposure Induced Glucose Homeostasis Disorder
$392,843Jen-Chywan Wang · University Of California Berkeley · R01 · FY2022 · DK
Glycans in Hepatocellular Carcinoma
$392,840Radoslav Goldman · Georgetown University · R01 · FY2012 · CA
Nonstructural 4B protein and hepatitis C virus replication complex
$392,758Kouacou V. Konan · Albany Medical College · R56 · FY2011 · AI
Role of Insulin Receptor Substrates in Kras-driven lung cancer
$392,740Nada Y. Kalaany · Boston Children'S Hospital · R01 · FY2019 · CA
Precise image guidance for liver cancer stereotactic body radiotherapy using element-resolved motion-compensated cone beam CT
$392,734Xun Jia · Ut Southwestern Medical Center · R01 · FY2021 · CA
Pathogenesis and Treatment of Alcohol-Induced Cirrhosis
$392,693New York University School Of Medicine · R01 · FY2004 · AA
High throughput screen for selective inhibitors of cyclophilin B
$392,671Richard J Bram · Mayo Clinic Rochester · R01 · FY2014 · NS
Molecular Characterization of Joubert Syndrome
$392,667Joseph G Gleeson · University Of California, San Diego · R01 · FY2011 · NS
Lower Vulnerability to Toxins in Aging by Treatment with Lipoic Acid
$392,652Tory M Hagen · Oregon State University · P01 · FY2009 · AT
FUNCTION OF THE HEMOCHROMATOSIS PROTEIN
$392,651Caroline Enns · Oregon Health & Science University · R01 · FY2007 · DK
Rapid Motion-Robust and Easy-to-Use Dynamic Contrast-Enhanced MRI for Liver Perfusion Quantification
$392,645Li Feng · New York University School Of Medicine · R01 · FY2024 · EB